» Articles » PMID: 22645149

Novel Anti-inflammatory Activity of Epoxyazadiradione Against Macrophage Migration Inhibitory Factor: Inhibition of Tautomerase and Proinflammatory Activities of Macrophage Migration Inhibitory Factor

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 May 31
PMID 22645149
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophage migration inhibitory factor (MIF) is responsible for proinflammatory reactions in various infectious and non-infectious diseases. We have investigated the mechanism of anti-inflammatory activity of epoxyazadiradione, a limonoid purified from neem (Azadirachta indica) fruits, against MIF. Epoxyazadiradione inhibited the tautomerase activity of MIF of both human (huMIF) and malaria parasites (Plasmodium falciparum (PfMIF) and Plasmodium yoelii (PyMIF)) non-competitively in a reversible fashion (K(i), 2.11-5.23 μm). Epoxyazadiradione also significantly inhibited MIF (huMIF, PyMIF, and PfMIF)-mediated proinflammatory activities in RAW 264.7 cells. It prevented MIF-induced macrophage chemotactic migration, NF-κB translocation to the nucleus, up-regulation of inducible nitric-oxide synthase, and nitric oxide production in RAW 264.7 cells. Epoxyazadiradione not only exhibited anti-inflammatory activity in vitro but also in vivo. We tested the anti-inflammatory activity of epoxyazadiradione in vivo after co-administering LPS and MIF in mice to mimic the disease state of sepsis or bacterial infection. Epoxyazadiradione prevented the release of proinflammatory cytokines such as IL-1α, IL-1β, IL-6, and TNF-α when LPS and PyMIF were co-administered to BALB/c mice. The molecular basis of interaction of epoxyazadiradione with MIFs was explored with the help of computational chemistry tools and a biological knowledgebase. Docking simulation indicated that the binding was highly specific and allosteric in nature. The well known MIF inhibitor (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1) inhibited huMIF but not MIF of parasitic origin. In contrast, epoxyazadiradione inhibited both huMIF and plasmodial MIF, thus bearing an immense therapeutic potential against proinflammatory reactions induced by MIF of both malaria parasites and human.

Citing Articles

Prenatal Exposure to Azadiradione Leads to Developmental Disabilities.

Jana S, Das S, Giri B, Archak R, Bandyopadhyay S, Jana N Mol Neurobiol. 2024; 62(3):3601-3614.

PMID: 39312066 DOI: 10.1007/s12035-024-04493-x.


Therapeutic Opportunities in Breast Cancer by Targeting Macrophage Migration Inhibitory Factor as a Pleiotropic Cytokine.

Khezrian A, Shojaeian A, Boroujeni A, Amini R Breast Cancer (Auckl). 2024; 18:11782234241276310.

PMID: 39246383 PMC: 11380135. DOI: 10.1177/11782234241276310.


Nimbolide: promising agent for prevention and treatment of chronic diseases (recent update).

Rajendran P, Renu K, Abdallah B, Ali E, Veeraraghavan V, Sivalingam K Food Nutr Res. 2024; 68.

PMID: 38571915 PMC: 10989234. DOI: 10.29219/fnr.v68.9650.


Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke.

Yang L, Guttman L, Dawson V, Dawson T Biochem Pharmacol. 2024; 228:116174.

PMID: 38552851 PMC: 11410548. DOI: 10.1016/j.bcp.2024.116174.


Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome.

Mohammad A, Laboulaye M, Shenhar C, Dobberfuhl A Nat Rev Urol. 2024; 21(7):433-449.

PMID: 38326514 DOI: 10.1038/s41585-023-00850-y.


References
1.
Cho Y, Jones B, Vermeire J, Leng L, DiFedele L, Harrison L . Structural and functional characterization of a secreted hookworm Macrophage Migration Inhibitory Factor (MIF) that interacts with the human MIF receptor CD74. J Biol Chem. 2007; 282(32):23447-56. PMC: 3707627. DOI: 10.1074/jbc.M702950200. View

2.
Augustijn K, Kleemann R, Thompson J, Kooistra T, Crawford C, Reece S . Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor. Infect Immun. 2006; 75(3):1116-28. PMC: 1828592. DOI: 10.1128/IAI.00902-06. View

3.
Starlets D, Gore Y, Binsky I, Haran M, Harpaz N, Shvidel L . Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood. 2006; 107(12):4807-16. DOI: 10.1182/blood-2005-11-4334. View

4.
Kamir D, Zierow S, Leng L, Cho Y, Diaz Y, Griffith J . A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J Immunol. 2008; 180(12):8250-61. PMC: 2668862. DOI: 10.4049/jimmunol.180.12.8250. View

5.
Hawkins O, Verma B, Lightfoot S, Jain R, Rawat A, McNair S . An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol. 2011; 186(11):6607-16. DOI: 10.4049/jimmunol.1003995. View